Publikationen von Philip Maximilian Knaff

Müller, P.; Maus, H.; Hammerschmidt, S. J.; Knaff, P. M.; Mailänder, V.; Schirmeister, T.; Kersten, C.: Interface with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy. Current Medicinal Chemistry 29 (4), S. 635 - 665 (2022)

Wettstein, L.; Weil, T.; Conzelmann, C.; Müller, J. A.; Gross, R.; Hirschenberger, M.; Seidel, A.; Klute, S.; Zech, F.; Bozzo, C. P. et al.; Preising, N.; Fois, G.; Lochbaum, R.; Knaff, P. M.; Mailänder, V.; Staendker, L.; Thal, D. R.; Schumann, C.; Stenger, S.; Kleger, A.; Lochnit, G.; Mayer, B.; Ruiz-Blanco, Y. B.; Hoffmann, M.; Sparrer, K. M. J.; Poehlmann, S.; Sanchez-Garcia, E.; Kirchhoff, F.; Frick, M.; Muench, J.: Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nature Communications 12, 1726 (2021)

Knaff, P. M.; Kersten, C.; Willbold, R.; Champanhac, C.; Crespy, D.; Wittig, R.; Landfester, K.; Mailänder, V.: From In Silico to Experimental Validation: Tailoring Peptide Substrates for a Serine Protease. Biomacromolecules 21 (4), S. 1636 - 1643 (2020)

Knaff, P. M.: Development of Peptidomimetic Substrates and Inhibitors for Transmembrane Serine Proteases. Dissertation, Johannes Gutenberg-Universität, Mainz (2021)